You are here: Welcome » pharmaceutical_companies » Novavax

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Next revision		Previous revision
Both sides next revision
pharmaceutical_companies:novavax [2022/08/21 02:15]
liam created		pharmaceutical_companies:novavax [2023/07/18 18:44] (current)
liam
Line 1: Line 1:
 ====== Novavax ====== ====== Novavax ======
 +
 +{{ :pharmaceutical_companies:novavax_logo_.png?200|}}
  
 Gaithersburg, Maryland, USA based publicly listed biotech company (NVAX) incorporated in 1987 that created a protein subunit vaccine for Covid-19 called [[covid-19_vaccines:nvx-cov2373]].  Gaithersburg, Maryland, USA based publicly listed biotech company (NVAX) incorporated in 1987 that created a protein subunit vaccine for Covid-19 called [[covid-19_vaccines:nvx-cov2373]]. 
Line 65: Line 67:
  
 The FDA, an agency within the U.S. Department of [[:Health and Human Services]], protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products. The FDA, an agency within the U.S. Department of [[:Health and Human Services]], protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
 +
 +===== External links =====
 +
 +  * [[http://covidtruthinitiative.ca/e/en/Organizations/Novavax|COVID Truth Initiative]]
 +
 +==== Links to sort ====
 +
 +  * [[https://www.canada.ca/en/innovation-science-economic-development/news/2021/02/backgrounder--government-of-canada-investments-in-covid-19-vaccines-and-biomanufacturing-capacity.html|Manufacturing deal with National Research Council of Canada's Biologics Manufacturing Centre]]
Back to top